Arkolith/Insider Trading/SGMO/Form 4

Macrae Sandy

PRESIDENT, CEO AND DIRECTOR, DirectorSANGAMO THERAPEUTICS, INC (SGMO) · full profile →Form 4 · filed Feb 26, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 25, 2026Tax withholding(F)34K$0.47$16K1.9M
Feb 24, 2026Tax withholding(F)5K$0.47$2K1.9M

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001675687-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML